Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3744 results

Sort By:

Identification of the Metabolic Signature of Atrial Fibrillation for Personalized Prevention

Study ID: NCT06735001
Start Date: 2025-02
End Date: 2027-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

400

Intervention / Treatment

FA ablation

Lab test

Sponsor

University Hospital, Bordeaux

Source: clinicaltrials.gov

Share:
Add to list

Efficacy of Mobile-delivered Sleep Restriction Therapy for Treatment of Insomnia Disorder: Randomised Controlled Trial

Study ID: NCT06114901
Start Date: 2025-02-01
End Date: 2028-10-26
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

558

Intervention / Treatment

SleepFix

Sleep health Education modules

Sponsor

Woolcock Institute of Medical Research

Source: clinicaltrials.gov

Share:
Add to list

Child-Parent Familial Hypercholesterolemia Screening

Study ID: NCT04529967
Start Date: 2025-04-01
End Date: 2026-09-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

15000

Intervention / Treatment

no interventions

Sponsor

Children's Hospital of Fudan University

Source: clinicaltrials.gov

Share:
Add to list

Methamphetamine, PrEP, and Intersectional Stigma Study

Study ID: NCT05784467
Start Date: 2025-06-01
End Date: 2027-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Methamphetamine, PrEP, and Intersectional Stigma (eMPrISe) study

Sponsor

Arizona State University

Source: clinicaltrials.gov

Share:
Add to list

Clinical Study of HRS-2129 for Postoperative Analgesia in Orthopaedics

Study ID: NCT06780267
Start Date: 2025-02-15
End Date: 2025-06-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

40

Intervention / Treatment

HRS-2129

HRS-2129

HRS-2129 placebo

Sponsor

Shandong Suncadia Medicine Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Nebivolol ANOCA Treatment Randomized Trial

Study ID: NCT06755801
Start Date: 2025-04-01
End Date: 2026-09-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

150

Intervention / Treatment

Nevibolol

Placebo

Sponsor

Spanish Society of Cardiology

Source: clinicaltrials.gov

Share:
Add to list

Pharmacogenomic Informed Statin Prescribing

Study ID: NCT06568601
Start Date: 2025-02-01
End Date: 2028-07-28
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

410

Intervention / Treatment

Pharmacogenetic and polygenic risk testing

Active control

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

A Real-World Study of Neoadjuvant/Conversion Therapy for Locally Advanced or Metastatic Gastric Cancer

Study ID: NCT06464601
Start Date: 2025-04-01
End Date: 2027-03-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

70

Intervention / Treatment

fruquintinib combined with immune checkpoint inhibitors and chemotherapy

fruquintinib combined with immune checkpoint inhibitors and chemotherapy

Sponsor

Wuhan University

Source: clinicaltrials.gov

Share:
Add to list

A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of Dual Immune Checkpoint Inhibition With Anti-PD-L1 (Atezolizumab) and Anti-TIGIT (Tiragolumab) in Cancer of Unknown Primary

Study ID: NCT06754501
Start Date: 2025-06-30
End Date: 2029-07-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

35

Intervention / Treatment

Atezolizumab

Tiragolumab

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Enabling Microbiomics- Driven Personalized Nutrition

Study ID: NCT06657001
Start Date: 2025-02
End Date: 2026-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

4001

Intervention / Treatment
Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list